| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBCAN.2014.09.004 |
| P698 | PubMed publication ID | 25270772 |
| P50 | author | Monique G P van der Wijst | Q85429880 |
| P2093 | author name string | Marianne G Rots | |
| Robert Brown | |||
| P2860 | cites work | Src Subfamily Kinases Regulate Nuclear Export and Degradation of Transcription Factor Nrf2 to Switch Off Nrf2-mediated Antioxidant Activation of Cytoprotective Gene Expression | Q28392546 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 494-509 | |
| P577 | publication date | 2014-09-28 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Nrf2, the master redox switch: the Achilles' heel of ovarian cancer? | |
| P478 | volume | 1846 |
| Q36244900 | Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma. |
| Q37134317 | Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage |
| Q90731783 | Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology |
| Q57069735 | Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review |
| Q55028564 | Developing a genetic signature to predict drug response in ovarian cancer. |
| Q49963024 | Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line. |
| Q38869922 | Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. |
| Q38632920 | Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation |
| Q47413250 | Functional analysis of Cullin 3 E3 ligases in tumorigenesis. |
| Q39285687 | HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation |
| Q26774902 | High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer |
| Q52569480 | Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer. |
| Q60926305 | Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients |
| Q33850055 | Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load |
| Q41229556 | Schisandra sphenanthera extract (Wuzhi Tablet) protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice |
| Q26770933 | Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives |
| Q41136568 | Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion. |
| Q26772298 | The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance |
| Q48214395 | The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy. |
| Q33598372 | The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells |
Search more.